REA, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 42.058
AS - Asia 24.673
EU - Europa 10.974
AF - Africa 3.986
SA - Sud America 3.923
Continente sconosciuto - Info sul continente non disponibili 811
OC - Oceania 386
Totale 86.811
Nazione #
US - Stati Uniti d'America 39.440
SG - Singapore 7.381
CN - Cina 3.863
VN - Vietnam 3.851
HK - Hong Kong 2.685
IT - Italia 2.597
BR - Brasile 2.347
BD - Bangladesh 1.486
DE - Germania 908
FI - Finlandia 856
FR - Francia 850
IN - India 706
CA - Canada 557
SE - Svezia 529
GB - Regno Unito 518
PL - Polonia 499
UA - Ucraina 461
RU - Federazione Russa 417
NL - Olanda 372
IQ - Iraq 365
TR - Turchia 322
AR - Argentina 317
JP - Giappone 290
PH - Filippine 257
ID - Indonesia 251
MX - Messico 242
EC - Ecuador 218
ES - Italia 216
PK - Pakistan 215
SA - Arabia Saudita 213
ZA - Sudafrica 206
CO - Colombia 185
KR - Corea 180
BJ - Benin 176
VE - Venezuela 173
UZ - Uzbekistan 172
AT - Austria 171
IE - Irlanda 152
MY - Malesia 152
CR - Costa Rica 150
JO - Giordania 142
MA - Marocco 140
CI - Costa d'Avorio 135
JM - Giamaica 135
TN - Tunisia 133
AO - Angola 131
TH - Thailandia 128
DZ - Algeria 127
AE - Emirati Arabi Uniti 124
EG - Egitto 124
BE - Belgio 123
CL - Cile 123
CZ - Repubblica Ceca 123
NP - Nepal 123
PY - Paraguay 123
AL - Albania 120
NI - Nicaragua 120
ET - Etiopia 119
PE - Perù 119
AZ - Azerbaigian 118
HN - Honduras 117
PA - Panama 116
BO - Bolivia 115
LB - Libano 114
PR - Porto Rico 113
UY - Uruguay 113
GT - Guatemala 111
SN - Senegal 111
KE - Kenya 110
PS - Palestinian Territory 108
TT - Trinidad e Tobago 106
UG - Uganda 106
CY - Cipro 105
DO - Repubblica Dominicana 104
NO - Norvegia 103
RO - Romania 103
HU - Ungheria 102
KG - Kirghizistan 102
MD - Moldavia 102
RS - Serbia 102
SI - Slovenia 102
IR - Iran 101
KZ - Kazakistan 101
CH - Svizzera 99
PT - Portogallo 99
AU - Australia 98
BY - Bielorussia 98
IL - Israele 98
ML - Mali 98
MU - Mauritius 96
XK - ???statistics.table.value.countryCode.XK??? 96
CU - Cuba 94
GN - Guinea 94
HR - Croazia 94
YT - Mayotte 93
CM - Camerun 92
EE - Estonia 92
GE - Georgia 91
LV - Lettonia 91
ME - Montenegro 91
Totale 81.557
Città #
Ashburn 4.998
Singapore 4.479
San Jose 4.398
Fairfield 3.898
Hong Kong 2.380
Woodbridge 2.207
Chandler 2.064
Houston 1.669
Seattle 1.349
Cambridge 1.330
Wilmington 1.240
Ho Chi Minh City 1.151
Ann Arbor 1.131
Jacksonville 943
Council Bluffs 913
Hanoi 911
Los Angeles 903
Santa Clara 885
Beijing 804
Boardman 625
New York 566
Princeton 504
San Diego 452
Lauterbourg 416
Helsinki 405
Chicago 297
Buffalo 287
Des Moines 262
Bytom 260
Milan 259
Munich 258
Medford 255
Rome 230
São Paulo 229
Da Nang 223
Dong Ket 222
Dallas 205
Roxbury 192
Padova 184
Nanjing 182
Hefei 176
Tokyo 168
Orem 167
Cotonou 164
Guangzhou 163
Tashkent 145
Haiphong 140
Baghdad 138
Warsaw 137
Abidjan 130
London 129
Dublin 128
Montreal 128
Amman 127
Atlanta 126
Brooklyn 126
Managua 117
Phoenix 117
Turku 115
Frankfurt am Main 113
Nuremberg 112
Luanda 111
San José 110
Dakar 109
Panama City 109
Toronto 106
Baku 105
Kampala 103
Johannesburg 101
Padua 101
Montevideo 100
Naples 98
Vienna 98
Nairobi 94
Conakry 93
Addis Ababa 92
Bishkek 91
Chennai 91
Seoul 90
Bamako 89
Libreville 88
Stockholm 87
Havana 86
Castries 83
Nassau 82
Podgorica 81
Amsterdam 80
Bangkok 79
Jeddah 79
Riga 79
Ulan Bator 79
Andorra la Vella 78
Guayaquil 77
Istanbul 77
Phnom Penh 76
Salt Lake City 76
Antananarivo 75
Nouakchott 75
Lima 74
Noumea 74
Totale 50.508
Nome #
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer 549
Thymectomy in Ocular Myasthenia Gravis: Results Before and After Generalization and Prognostic Predictors of Outcomes 520
Extended criteria donor lung reconditioning with the organ care system lung: a single institution experience 389
211P: Inflammatory cells characterization and localization in malignant pleural mesothelioma (MPM) tissue samples: Correlation with histologic subtype and prognosis 359
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 354
A 72-year-old woman with previous pulmonary metastasis and new peripheral nodule 353
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intra-tumor heterogeneity over time 347
Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal 344
Predictors of behaviour in solitary fibrous tumours of the pleura surgically resected: Analysis of 107 patients 311
Organ Care System Lung resulted in lower apoptosis and iNOS expression in donor lungs 303
Immediate and Catastrophic Antibody-Mediated Rejection in a Lung Transplant Recipient With Anti-Angiotensin II Receptor Type 1 and Anti-Endothelin-1 Receptor Type A Antibodies 303
Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections? 302
Higher Risk of Acute Cellular Rejection in Lung Transplant Recipients with Cystic Fibrosis 297
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: Correlation with pathological and clinical data 294
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. 290
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 290
Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment 285
28P Different genetic profiling in lung adenocarcinoma of smokers with and without chronic obstructive pulmonary disease (COPD): An exploratory analysis by next generation sequencing (NGS) 285
COPD-related adenocarcinoma presents low aggressiveness morphological and molecular features compared to smoker tumours. 284
Patterns of Comorbidities in Lung Cancer Patients and Survival 283
Synergistic Antitumor Activity of Recombinant Human Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Combination with Carboplatin and Pemetrexed in Malignant Pleural Mesothelioma 282
Immune inflammation and disease progression in idiopathic pulmonary fibrosis 280
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes 280
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 278
Experience with the "da Vinci" robotic system for thymectomy in patients with myasthenia gravis: Report of 33 cases 277
Benign tracheal and laryngotracheal stenosis: surgical treatment and results 276
CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline 274
Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman 271
Feasibility and Utility of Chest-X ray on Portable Normothermic Perfusion System 267
A quarter of a century experience with sleeve lobectomy for non-small cell lung cancer. 266
Diagnostic and Therapeutic Management of the Thoracic Outlet Syndrome. Review of the Literature and Report of an Italian Experience 262
RNA Sequencing of Epithelial Cell/Fibroblastic Foci Sandwich in Idiopathic Pulmonary Fibrosis: New Insights on the Signaling Pathway 261
CHEMOTHERAPY OF INVASIVE THYMOMA 260
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology 259
A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis 259
Giant cell interstitial pneumonia: case series with comprehensive ultrastructural analyses of “not only” hard metal pneumoconiosis 257
Asymptomatic Pulmonary Allograft Kaposi Sarcoma: A Case Report 255
Noninvasive high-frequency percussive ventilation in the prone position after lung transplantation. 255
Non-Small-Cell Lung Cancer: Real-World Cost Consequence Analysis 254
A new vessel filled and heart-beating human corpse model for VATS lobectomy training 254
Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection 251
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 251
Extrapleural pneumonectomies for pleural mesothelioma 249
An Unusual Cause of Thoracic Outlet Syndrome 247
Timectomia robotica con accesso sinistro 245
Thymic Carcinoma With Thyroid Transcription Factor-1 Expression: An Insidious Pitfall 245
Unexpected pleural finding after a fall 244
Lung ultrasound as a monitoring tool in lung transplantation in rodents: a feasibility study 244
Long-term results of surgical management of pulmonary metastases from renal cell carcinoma 243
Is "lung repair centre" a possible answer to organ shortage?-transplantation of left and right lung at two different centres after ex vivo lung perfusion evaluation and repair: case report 243
Ex-vivo recruitment and x-ray assessment of donor lungs in a challenging retrieval from a donor supported by lvad using the portable normothermic perfusion system: A case report 242
Multidrug-Resistant and Extended-Spectrum β-Lactamase Gram-Negative Bacteria in Bilateral Lung Transplant Recipients: Incidence, Risk Factors, and In-Hospital Mortality 241
Video assisted thoracic surgery (VATS) for recurrent thymoma 241
α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency 241
Synergistic antitumor activity of recombinant human Apo2L/Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma 241
Multi-drug resistant and extended spectrum beta-lactamase Gram-negative bacteria in bilateral lung transplant recipients. Incidence, risk factors and in-hospital mortality 239
Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification 239
Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma 239
Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study 238
Blood Products Transfusion and Mid-Term Outcomes of Lung Transplanted Patients Under Extracorporeal Membrane Oxygenation Support 238
Sleeve resections and bronchoplastic procedures in typical central carcinoid tumours 237
Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients 236
Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis 234
Single-center experience in urgent lung transplantation program in a country with a shortage of donors: Does the end justify the means? 234
Long-Term Results and Prognostic Factors of Pulmonary Metastasectomy in Patients with Metastatic Transitional Cell Carcinoma 233
Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations. 232
Multidrug-Resistant and Extended-Spectrum β-Lactamase Gram-Negative Bacteria in Bilateral Lung Transplant Recipients: Incidence, Risk Factors, and In-Hospital Mortality 231
Increased tissue endothelial progenitor cells in end-stage lung diseases with pulmonary hypertension. 231
Recurrence of idiopathic pulmonary hemosiderosis in a young adult patient after bilateral single-lung transplantation 231
Indications and results of sternal allograft transplantation: learning from a worldwide experience 231
The Psychosocial Assessment of Transplant Candidates: Inter-Rater Reliability and Predictive Value of the Italian Stanford Integrated Psychosocial Assessment for Transplantation 230
Normothermic Perfusion of Donor Marginal Lungs with the Organ Care System Lung: Clinical and Morphologic Evaluation 230
Morbidity, mortality, and survival after bronchoplastic procedures for lung cancer 229
Three-Dimensional Imaging-Guided Lung Anatomic Segmentectomy: A Single-Center Preliminary Experiment 229
A new technique of diaphragmatic patch fixation in extrapleural pneumonectomy 228
Enhanced recovery after elective surgery for lung cancer patients: Analysis of current pathways and perspectives 228
The rarest of rare thymic lesions: A 10-year surgical pathology experience 228
Tertiary lymphoid structures and B-cell infiltration are IPF features with functional consequences 228
Surgery for T4 lung cancer invading the thoracic aorta: Do we push the limits? 227
Changes in pulmonary function tests predict radiological response to chemotherapy in malignant pleural mesothelioma. 227
VATS right basal segmentectomy for NSCLC in a patient with systemic sclerosis 227
Robotic thymectomy in thymic tumours: a multicentre, nation-wide study 225
Successful Treatment of a Recurrent Wide Tracheoesophageal Fistula With a Bioabsorbable Patch 225
Comparison of operative and postoperative characteristics and outcomes between thoracoscopic segmentectomy and lobectomy for non-small-cell lung cancer: a propensity score matching study from the Italian VATS Group Registry 225
A METHOD FOR THE PULMONARY AEROSTASIS AND A DEVICE FOR ITS APPLICATION 224
Pushing the limits of reconditioning: Extended normothermic lung perfusion in an extended criteria donor 224
Extensive abdominal and chest wall resection and reconstruction for invasive squamous cell carcinoma of the skin 224
Somatostatin and D2 Receptor Immunohistochemistry in a Series of Lung and Gastroenteropancreatic Neuroendocrine Tumors: Correlation with in vivo Scintigraphic Data 223
Robotic Thymectomy for Myasthenia Gravis: Analysis of the Surgical and Neurological Outcomes After a 20 Years' Experience 222
Pediatric congenital pulmonary malformations: key findings at imaging 221
Sindrome dell'egresso toracico: indicazioni multidisciplinri all'intervento chirurgico 221
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 221
The surplus transplant lung allocation system in italy: An evaluation of the allocation process via stochastic modeling 221
Comprehensive bronchoalveolar lavage characterization in COVID-19 associated acute respiratory distress syndrome patients: a prospective cohort study 219
CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis 219
Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? A Clinico-Pathological and Molecular Study 218
Airway inflammation in severe chronic obstructive pulmonary disease 218
Somatostatin receptor type 2 (SSTR2) in bronchopulmonary carcinoids. 218
Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure 218
Adult Benign, Non-Iatrogenic Bronchoesophageal Fistulae: Systematic Review and Descriptive Analysis of Individual Patient Data 217
Totale 25.974
Categoria #
all - tutte 249.113
article - articoli 232.484
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 596
selected - selezionate 0
volume - volumi 3.610
Totale 485.803


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.506 0 0 636 328 296 447 289 521 420 139 421 1.009
2022/20234.081 785 425 151 445 627 517 44 270 515 47 193 62
2023/20242.151 84 289 272 228 141 238 150 140 102 45 228 234
2024/20259.968 18 687 443 282 1.220 352 591 823 827 370 1.645 2.710
2025/202646.573 2.057 3.364 5.891 7.133 3.916 2.053 6.729 3.988 4.369 2.645 2.362 2.066
2026/20274.271 2.128 1.890 253 0 0 0 0 0 0 0 0 0
Totale 86.811